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medium, provided the original work is properly cited.Identification of tissue-specific renal stem/progenitor cells with nephrogenic
potential is a critical step in developing cell-based therapies for renal disease. In
the human kidney, stem/progenitor cells are induced into the nephrogenic
pathway to form nephrons until the 34 week of gestation, and no equivalent cell
types can be traced in the adult kidney. Human nephron progenitor cells (hNPCs)
have yet to be isolated. Here we show that growth of human foetal kidneys in
serum-free defined conditions and prospective isolation of NCAM1þ cells selects
for nephron lineage that includes the SIX2-positive cap mesenchyme cells
identifying a mitotically active population with in vitro clonogenic and stem/
progenitor properties. After transplantation in the chick embryo, these cells—but
not differentiated counterparts—efficiently formed various nephron tubule
types. hNPCs engrafted and integrated in diseasedmurine kidneys and treatment
of renal failure in the 5/6 nephrectomy kidney injury model had beneficial effects
on renal function halting disease progression. These findings constitute the first
definition of an intrinsic nephron precursor population, with major potential for
cell-based therapeutic strategies and modelling of kidney disease.ond and Lily Safra
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Nearly 26 million Americans, one in every nine, harbour kidney
disease (Trivedi, 2010). Despite recent medical advances, the
treatment options for patients with renal failure are limited. The
alternatives available to patients who succumb to terminal renal
disease are either supportive treatment in the form of dialysis or
whole organ replacement by kidney transplantation. Dialysis is
associated with long‐term morbidity, mortality and poor quality
of life. The shortage of donor organs and the long wait time on
the recipient list hamper renal transplantation (Daar, 2006). The
number of patients with terminal renal disease has increased,
and the treatment costs for these patients now exceed the
cumulative costs of treating cancer patients (Trivedi, 2010).
Against this background of the growing number of patients with
kidney disease and the limited treatment options, alternative
treatments are clearly in need.
Various types of stem cells may be applicable as a platform
for cell therapy for renal disease (Pleniceanu et al, 2010;is is an open access article under
ion and reproduction in any
EMBO Mol Med (2013) 5, 1556–1568
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bone marrow and blood stem cells do not generate nephron cell
types (Dufﬁeld et al, 2005; Krause & Cantley, 2005; Dekel et al,
2006b) and (b) the existence of an adult kidney epithelial stem
cell with wide nephrogenic potential is still tenuous. Hence,
isolation of tissue stem/progenitor cells from foetal kidneys is an
attractive option for replenishment of nephron cells (Pleniceanu
et al, 2010; Harari‐Steinberg et al, 2011). The mammalian kidney
is formed via reciprocally inductive interactions between two
mesoderm precursor tissues, the metanephric mesenchyme
(MM) and the ureteric bud (UB) (Pleniceanu et al, 2010). In
response to UB signals, induced MM cells acquire an epithelial
phenotype (mesenchymal to epithelial transition; MET) to
generate committed nephron progenitor populations and
sequentially form the pretubular aggregate, renal vesicle and
C‐ and S‐shaped bodies that expand to give rise to the mature
nephron (Pleniceanu et al, 2010). Recent lineage tracing
experiments of cell populations in transgenic mouse models
have established that the transcription factor Six2 signiﬁes a
multipotent progenitor cell in the MM that condensates to form
cap mesenchyme (CM) around the UB and is capable of self‐
renewing and of differentiating towards different types of
nephron epithelia (Boyle et al, 2008; Kobayashi et al, 2008).
Nevertheless, only a few studies have utilized human foetal
kidney (hFK) as starting material for regenerative purposes, and
most employ tissue transplantation rather than derivation of
speciﬁc human cell types suitable for in vitro manipulation and
cell therapy (Dekel et al, 1997, 2002, 2003; Hammerman, 2000).
Progenitor cell types in the MM have been previously isolated
from embryonic mouse kidneys by means of a supply of the
nephrogenic inducer, Wnt4 (Osafune et al, 2006), or by growing
cells as nephrospheres, which, although robustly propagated
in vitro, failed to display renal epithelial/nephrogenic capacity
(Lusis et al, 2010).
With the intention of prospectively isolating progenitor
populations from hFK by ﬂow cytometry, we carried out global
gene analysis (Dekel et al, 2006a) followed by protein expression
studies (Metsuyanim et al, 2009) to pinpoint phenotypic surface
markers that would replace intra‐cellular renal transcription
factors not relevant for sorting from human tissue, among
them the neural cell adhesion molecule 1 (NCAM1). In the
current study, by utilizing clonal analysis, deﬁned serum‐free
culture conditions, and cell sorting with NCAM1, we were
able, for the ﬁrst time, to isolate a progenitor population from
mid‐gestation hFKs strongly committed to nephron formation
and displaying beneﬁcial effects in a mouse model of chronic
renal failure.RESULTS
NCAM1þ cells are enriched for embryonic renal stem cell
markers
There has been considerable effort to identify cell surface
markers to prospectively isolate stem cell populations from the
kidney. We have previously put forward NCAM1 as a candidate
marker for this (Dekel et al, 2006a; Metsuyanim et al, 2009). InEMBO Mol Med (2013) 5, 1556–1568 fact, repeated veriﬁcation by microarray analysis comparing
human foetal and adult kidneys revealed NCAM1 as the
most differentially expressed cell surface marker (>23‐fold).
Work in transgenic mouse models has identiﬁed Six2 in the CM
as self‐renewing nephron stem/progenitor cells (Kobayashi
et al, 2008). To compare expression patterns in the developing
kidney we co‐stained organ cultures of embryonic mouse
kidneys with antibodies for Ncam1, Six2 and Cdh1/E‐cadherin
(Fig 1A). As previously described in hFK sections (Metsuyanim
et al, 2009), Ncam1 in mouse organ culture was found expressed
in the CM, as well as the earliest differentiated structures (renal
vesicle, comma and S‐shaped bodies). Six2 expression was
solely found in the CM. Expression of Cdh1 as marker for
epithelial cells was found to be almost mutually exclusive with
Six2 expression, conﬁrming the pre‐MET expression of Six2,
although occasionally we found co‐expression of Six2 and Cdh1
as cells were going through the MET. It is not clear if these cells
still express new Six2 protein, or whether they simply have not
lost the existing protein yet. Therefore, Ncam1 expression was
found in pre‐ and post‐MET stages.
We queried a genomic data set from the GUDMAP database
based on cell‐type‐speciﬁc gene expression proﬁles derived from
a series of GFP‐transgenic mouse lines and FACS separated
lineages, each representing a speciﬁc developmental compart-
ment regulated temporally and spatially (Harding et al, 2011). In
the mixed kidney sample ST 1.0 dataset, Ncam1 was clearly and
strikingly elevated in P0–P3 CM, corresponding to the time of
post‐natal nephrogenic burst observed in the mouse (Ncam1 is
strongly expressed in P1 CM, data not shown). To identify other
genes whose expression was co‐ordinately regulated with that of
Ncam1, we used Pearson correlation across these normalized
gene expression proﬁles and identiﬁed a group of genes that
exhibit essentially identical activation in P0‐P3 CM and become
somewhat inhibited at P4, consistent with the cessation of
nephrogenic burst activity (Supporting Information Fig S1).
The Ncam1 expression module, highly active in the peripartum
nephrogenic burst phase CM, remarkably disclosed an
overlap among neurogenic and nephrogenic programs and
highlighted key players in the nephrogenic differentiation
process (Supporting Information Fig S2). Interestingly, many
of these genes are targeted by miRs‐200b and 204, which
regulate epithelial–mesenchymal transitions (Mongroo &
Rustgi, 2010) and by the H3K27 repressive chromatin modiﬁca-
tion. Based on these results, the population of Ncam1þ cells
likely was heterogeneous, comprising a mix of stem and more
committed progenitor cells.
We next determined whether hFK cultures would retain the
NCAM1þ cells. For clinical applications in cell therapy, it is
essential that cells can be maintained and expanded under
deﬁned serum‐free conditions. We therefore cultured hFK cells
in serum‐free medium (SFM; Kreso & O’Brien, 2008) at low‐
density. Culturing in SFM generated compact colonies of small
round/cuboidal cells after 14 days in culture, whereas culturing
in serum‐containing medium (SCM) yielded dispersed ﬁbro-
blastic/spindle‐shaped cells (Fig 1B). At the early stage of the
isolation procedure serum may promote the selection and
expansion of stromal lineages and also dedifferentiation via2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 1557
Figure 1. NCAM1 expression in mouse embryonic kidney organ and hFK serum‐free cultures.
A. Mouse embryonic kidney organ culture stained for Ncam1, Six2 and E-cad as indicated. An enlargement of the Ncam/Six2 signal is shown to emphasize the
nuclear localization of Six2. White arrow illustrates the absence of Six2 signal in E-cad positive cells. An occurrence of Six2/E-cad positive cells is indicated with
the asterisk. Images were obtained using Nikon A1R confocal microscope with and processed in ImageJ/Fiji software.
B. Morphology of hFK cells cultured in SFM or SCM after 3 days (passage 0 Day 3—left panels) and towards confluence (14 days in SFM or 7 days in SCM—right
panels). Distinct borders appear in SFM cultures (arrows) whereas cells with different morphology (arrows) are observed in SCM culture. Cells were observed
using a Nikon Digital Sight camera attached to a Nikon Eclipse TS100 microscope.
C. qRT-PCR analysis of gene expression in hFK cells cultured in SFM (three independent replicates). hPRT1 was used as endogenous control and SCM cells were
used as the calibrator sample for RQ calculation (therefore¼1). Data were analysed using SDS 3.2 software.
D. Representative FACS analysis of NCAM1 expression in hFK cells cultured in SFM at passage1. Data is presented in a histogram graph showing NCAM1 staining
in blue and the isotype controls staining (negative control) in red.
E. Immunofluorescence staining of NCAM1 (red) in total hFK cells cultured in SFM. Nuclei stained with Dapi (blue). Images were obtained using Olympus DP72
camera attached to Olympus BX51 fluorescence microscope and processed via cellSens standard software.
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observedmorphologywe observed. This was tested via gene and
protein expression after one or two passages in SFM and
compared to hFK cells cultured in SCM. We analysed a set of
genes specifying undifferentiated mesenchymal renal progeni-
tors (OSR1, SIX2, PAX2, SALL1, WT1), MET genes (VIMENTIN,
VIM; CDH1/E‐CADHERIN, E‐CAD) and FOXD1 which marks
the stromal/interstitial lineage during renal development
(Hatini et al, 1996; Humphreys & Bonventre, 2008). qRT‐PCR
analysis indicated that SFM cultures excluded stroma and
deviated towards induced but immature epithelia and early post‐
MET state (Fig 1C). This was conﬁrmed using antibodies to
epithelial (EpCAM, CD24, CD133), mesenchymal (CD105,
CD90) and haematopoietic/endothelial (CD34) cell surface
markers (Supporting Information Fig S3A–C).
Having established that hFK cells cultured in serum‐free
deﬁned conditions skewed towards epithelial commitment but
not uninduced mesenchyme or stromal lineage, we reasoned
that derivation of NCAM1þ cells from hFK stroma where
expression is abundant (Metsuyanim et al, 2009) would be
eliminated while NCAM1 expressing cells originating from the
nephrogenic pathway retained. Accordingly, culture and growth
of hFK cells in SFM yielded a smaller NCAM1 expressing
population (range 5–20% in SFM; Fig 2D and E) compared to
SCM (>30% in SCM as described previously; Metsuyanim
et al, 2009).
Cultured NCAM1þ cells display essential stem/progenitor
properties
We next determined whether the cultured NCAM1þ cells
harbour stem cell characteristics. hFK cells were therefore
expanded in SFM and NCAM1‐positive cells were collected via
immunosorting (Supporting Information Fig S3D and E) and
analysed for the expression of nephron stem/progenitor cell
markers. We utilized at least three human foetal samples that
carry inherent variance and may hamper statistical signiﬁcance.
In the NCAM1þ cell population, we found signiﬁcant elevation
of the nephron progenitor markers compared to NCAM1 cells
(Fig 2A). Since NCAM1 is not detected in the UB epithelial
lineage, markers such as PAX2 which strongly express in UB and
derivatives were less enriched. Importantly, analysis of E‐CAD
levels showed signiﬁcant reduction in NCAM1þ cells, indicating
that under SFM conditions these cells resemble earlier stages of
induction towards mature nephrons than the NCAM1 sub‐
population. NCAM1þ immunosorted cells expanded in SCM
showed less enrichment in nephron progenitor gene expression
(Supporting Information Fig S3F). Expression analysis of
NCAM1þ cells with oligonucleotide microarrays that allow a
broader view of transcriptional changes (Supporting Information
Table S1) showed up‐regulation of multiple genes that positively
regulate cell cycle/cell division/cell growth, concomitantly, with
a reduction in genes associated with terminal epithelial
differentiation (Supporting Information Table S2). Analysis at
the protein level supported gene expression; immunoﬂuorescent
labelling of VIM and E‐CAD revealed lack of E‐CAD and positive
VIM staining in NCAM1þ cells, whereas NCAM cells showed
wide spread E‐CAD expression (Fig 2B and C). In addition, SIX2EMBO Mol Med (2013) 5, 1556–1568 immunostaining demonstrated enhanced expression in
NCAM1þ cells (Fig 2D–G, Supporting Information Fig S4)
revealing the presence of earlier NCAM1þ SIX2þ characteristi-
cally displaying bright nuclei and small cytoplasm and more
differentiated NCAM1þ SIX2 cell populations (Fig 2F). Thus,
we conﬁrmed the existence of SIX2þ and SIX2 sub populations
in NCAM1þ cells from hFK samples observed in the mouse
embryonic kidney cultures (Fig 1A).
Clonogenic capacity ofNCAM1‐positive and ‐negative cells was
analysed by limiting dilution. When cells were plated under
deﬁned SFM conditions, clonogenic activity of hFK cells was
found almost exclusively within the NCAM1þ fraction (Fig 2H
and I). Self‐renewal capacity of NCAM1þ cells was determined;
cells were able to expand from one cell with no supporting cells to
a clone that continued to expand up to three to four passages post‐
sorting maintaining a stable phenotype (Supporting Information
Fig S5A). Hence, nephron precursors, although harbouring
propensity for self‐renewal, do not undergo endless self‐renewing
divisions under these culture conditions. To further improve
expansion of NCAM1þ cells in SFM, we examined the addition of
niche factors that have been shown to support mice nephron
progenitors in vitro (Dudley et al, 1999). Only BMP7 in the
absence of ﬁbronectin increased cell numbers/survival by 50%
on average, but activating WNT signalling failed to show a
beneﬁcial effect (Supporting Information Fig S5B and C).
Having established that NCAM1 enriches for clonogenic and
progenitor properties of hFK cells, we determined whether
speciﬁc targeting of the NCAM1þ fraction would deplete these
properties. We therefore studied the effects of an antibody
drug conjugate (ADC), which targets and depletes NCAM1
expressing cells (IMGN901; humanized NCAM1 monoclonal
antibody covalently linked to the cytotoxic agent DM1; Lutz &
Whiteman, 2009; Pode‐Shakked et al, 2013) on clonogenicity/
self‐renewal capacity of hFK cells. Calibration assays were
performed to determine optimal ADC dosing, thus enabling the
elimination of the largest possible NCAM1þ cell fraction from
hFK cells without harming other cells (Supporting Information
Fig S5D and E). hFK primary cultures expanded in SFM were
treated with 55 nM IMGN901, while control samples were given
huN901 (NCAM1 antibody without the DM1 toxin) or left
untreated. After 7 days of treatment, IMGN901‐treated cultures
were nearly abolished of clonogenic capacity and clone failed to
propagate (Fig 2J), conﬁrming that the stem/progenitor activity
is contained in the NCAM1þ sub‐population.
In vitro cultured NCAM1þ cells retain in vivo nephrogenic
potential
To test the in vivo differentiation/organogenic capacities of SFM
cultured NCAM1þ cells we performed grafting experiments on
the chorio‐allantoic membrane (CAM) of a chick embryo, a
highly vascularized site supplying developmental cues (Buzhor
et al, 2011; Noiman et al, 2011). We have previously established
this as a model to analyse the ability of human kidney cell types
to generate renal structures; non‐renal cell types such as
bone marrowmesenchymal stem cells (MSCs) have consistently
failed (Buzhor et al, 2011; Noiman et al, 2011). No glomerular
structures are apparent in CAM grafts, as their complex assembly2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 1559
Figure 2. Characterization of immunosorted NCAM1þ subpopulation.
A. RT-PCR analysis of gene expression in NCAM1 cell fractions. GAPDH was used as endogenous control and NCAM1 cell were used as the calibrator sample
for RQ calculation (therefore¼1). Data were analysed using SDS 3.2 software and presented as average RQ SDEV of three replicates. p<0.001,
p<0.05 versus NCAM1.
B–D. Immunofluorescence staining of NCAM1þ and NCAM1 subpopulations for E-cadherin (E-cad) (B, red) vimentin (C, green) and SIX2 (D, green). Nuclei stained
with Dapi (blue). (B–C) Images were obtained using Olympus DP72 camera attached to Olympus BX51 fluorescence microscope and processed via cellSens
standard software, bar represents 200mm. (D) Images were obtained using Zeiss LSM 510 confocal microscope, bar represents 50mm.
E. Fluorescent quantification of SIX2 immunostaining as represented in (D).
F. Double labelling of sorted NCAM1þ cells for NCAM1 and SIX2: NCAM1 with DAPI (upper panel; red and blue channels), NCAM1 with SIX2 (lower panel;
red and green channels), indicating both NCAM1þ SIX2þ (arrows) and NCAM1þ SIX2 (arrowheads) cells.
G. Graph represents percentage of NCAM1þ SIX2þ cells and NCAM1þ SIX2 cells.
H. Clonogenic efficiency of NCAM1þ cells sorted from hFK and cultured in SFM. Data are presented as average CE(%) SDEV. p<0.01 versus NCAM1.
I. Representative morphology of NCAM1þ and NCAM1 clones. Cells were observed using a Nikon Digital Sight camera attached to a Nikon Eclipse
TS100 microscope.
J. Clonogenic capacity of hFK cells treated with IMGN901(ADC 55nM), huN901 (Ab55 nM) or not treated (control). Data are presented as average
CE(%) SDEV. p<0.001, p<0.05 versus control group.
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1560is not likely to be supported in the CAM assay. In this assay,
testing with different numbers of grafted human foetal cells
showed that only high cell numbers of unselected hFK cells
(2.5 106) could generate tubule‐like structures (Supporting
Information Fig 6A–E). When 1 105–5 105 NCAM1þ were 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.grafted we found identiﬁable tubular structures in 4/6 NCAM1þ
cell grafts (an order of magnitude compared to unselected cells),
while same numbers of NCAM1 cells completely failed
to generate similar structures (0/6 grafts; Fisher exact test,
p¼ 0.03; Fig 3A–C). The human origin of hFK tubular structuresEMBO Mol Med (2013) 5, 1556–1568
Figure 3. Segment‐speciﬁc differentiation of NCAM1þ cells on chick CAM.
A. Summarizing table of chick CAM results (cell type, cells/egg, visible grafts and grafts with tubule-like formations).
B,C. H&E staining of paraffin-embedded sections of 5105 NCAM1 (B) and 5105 NCAM1þ (C) cells. Yellow arrows mark the tubule-like formations. The
images were obtained using Scion colour digital camera attached to an Olympus BX51TF microscope.
D–F. Segment-specific IHC staining of DBA (D), LTA (E) and THG (F) in paraffin-embedded sections of 5105 NCAM1þ cell grafts. Yellow arrows mark the stained
tubule-like structures while orange arrows mark the unstained structures. Images were obtained using a Scion Corporation grayscale digital camera
attached to an Olympus BX51.
G,H. Segment-specific IF staining of DBA (G) and LTA (H) in paraffin-embedded sections of 5105 NCAM1þ cell grafts. Hoechst 33342 (blue) was used for nuclear
staining. Images were obtained using an Olympus AX70 motorized microscope and spectral unmixing which allows distinction of background from specific
staining, using a multispectral imaging system (NuanceFX camera and software).
Research Articlewww.embomolmed.org
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1562on the CAM was conﬁrmed by non‐cross reactive human‐
speciﬁc Ki‐67 antibodies, also indicating proliferative capacity of
formed tubules (Supporting Information Fig S6F–H). Addition-
ally, the epithelial marker panCK intensely stained the tubular
structures but not individual cells yet to differentiate and
organize (Supporting Information Fig S6I–K). We further
analysed tubular structures derived from NCAM1þ cells for
the presence of mature nephron cell types using markers speciﬁc
for proximal (LTA; lotus tetragonolobus lectin), loop of Henle
(anti‐THG; Tamm–Horsfall glycoprotein) and distal (DBA;
dolichos biﬂorus agglutinin) tubules. Immunostaining with
LTA, DBA and anti‐THG revealed the presence of all three
(Fig 3D–H), which were devoid of NCAM1 expression (data not
shown). Altogether, CAM grafting which enables the NCAM1þ
progenitors to undergo MET into mature epithelia demonstrates
their enriched and broad intrinsic differentiation capacity that
NCAM counterparts lack.
In vitro cultured NCAM1þ hNPCs improve the outcome of
chronic renal injury
The data presented so far convinced us that the SFM cultured
NCAM1þ cell population represents committed human nephron
progenitors (hNPCs). To demonstrate the clinical importance of
hNPCs, we carried out proof‐of‐principle experiments evaluating
functional renal parameters in a mouse model of renal injury. De
novo generation of mature renal cell types is likely to be relevant
in chronic progressive kidney disease (e.g. chronic proteinuric
states), in which nephron cells are progressively depleted. We
therefore tested the therapeutic effects of hNPCs in the 5/6
nephrectomy (Nx) chronic progressive kidney injury model. We
generated 5/6 Nx in 44 NOD/SCID mice and implemented a
protocol of three consecutive injections of 5 105 hNPCs directly
into the renal parenchyma (every 3 weeks) and followed treated
mice (n¼ 20) for a 14‐week period in comparison to untreated
mice (n¼ 24, saline injected; Supporting Information Fig S7A).
For conﬁrmation of cell engraftment hNPCs were labelled with
CellTracker and analysed 2 weeks after cell injection using an
in vivo imaging system (Fig 4A) and laser scanning confocal
microscopy (Supporting Information Fig S7B). These data, along
with the gene expression of human‐speciﬁc b2‐microglobulin
(hb2M) in the diseased murine kidney (Fig 4B, Supporting
Information Fig S7C), indicated robust engraftment of hNPCs.
The prolonged 5/6 Nx experiment enabled 24 h urinary
collection and repeated measurement of creatinine clearance
(CrCl) as a measure of renal function. For each time point we
analysed the change from baseline CrCl (1 week post 5/6 Nx)
among individual mice. At 12weeks, the proportion of mice with
a reduction of more than 15% in CrCl including mortality events
was signiﬁcantly lower in the hNPC treated group (5/20 mice)
compared to the untreated saline group (15/24 mice; Fisher
exact test, p¼ 0.01, Fig 4C). In addition, at 12 weeks but not in
earlier time points, there was signiﬁcant improvement in change
from baseline in the absolute CrCl values with mean differences
per minute of 0.034 0.04ml in the hNPC group versus
0.0137 0.019ml/min in the untreated group (t‐test, p¼ 0.01;
Fig 4D). Thus, treatment with hNPCs halted disease progression
and increased CrCl throughout the 12‐week study period, a 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.ﬁnding that is consistent with an improvement in kidney
function.
To further provide possible mechanistic insight as to the
effects of hNPCs via production of renal epithelium and cell
replacement we immunostained consecutive sections injured
kidneyswith human‐speciﬁcmarkers, HLA and panCK/MNF116
(Cohen et al, 2010; Eventov‐Friedman et al, 2005 and Supporting
Information Fig S7D showing non‐cross reactivity and speciﬁcity
for human kidney epithelia). Three patterns of engraftment were
observed, including integration into an existing mouse tubule
(Fig 4E, F and H), between tubules (Fig 4I) and tubular
regeneration (Fig 4E and G) consisting of small early tubules
staining for HLA, panCK and lacking NCAM1 that appeared
within 2 weeks (Fig 4J) and larger mature‐appearing epithelial
tubules with a patent lumen after 3 months (Fig 4K).
Furthermore, immunostaining with distal (EMA) and proximal
(ENPEP)markers disclosed renal identity (Fig 4L and Supporting
Information Fig S7E; Fig 4M and Supporting Information Fig S7F,
respectively). Altogether, repeated injection demonstrated that
hNPCs have integrated to a certain extent into the endogenous
mouse tissue, mixed with pre‐existing host cells, and regenerat-
ing injured kidney tissue.DISCUSSION
Using deﬁned culture conditions and NCAM1 immunosorting,
we succeeded for the ﬁrst time in prospectively isolating
committed nephron progenitors from hFK. We showed that
hNPCs have primitive characteristics that express distinct
nephron progenitor markers. hNPCs also expressed relatively
high levels of VIM and low levels of CDH1/E‐CAD, correspond-
ing to early stages of epithelial induction and conﬁrming their
primitive phenotype. Using clonal stem/progenitor cell assays,
we found that NCAM1‐expressing cells contain highly clono-
genic and self‐renewing cell populations (the latter to a limited
extent in our culture conditions). Clonal hNPC were highly
enriched for NCAM1 in SFM and NCAM1 targeting abrogated
hFK cell clonogenicity. When grafted on the chick CAM these
cells proved robustly tubulogenic in situ without the require-
ment of extra‐stromal compartment and were more efﬁcient
at renal differentiation than were unsorted cells (whole hFK)
and differentiated NCAM1 counterparts. Importantly, foetal
NCAM1þ cells not only exhibited rapid initiation of tubulo-
genesis but also broad nephron epithelial potential.
Previously, because of its mesodermal derivation, the hFK
and undifferentiated MM were used as a valuable source of
CD90þ plastic mesenchymal cells and MSC‐like cells that gave
rise to multiple lineages but not to kidney epithelial lineage
(Almeida‐Porada et al, 2002). Similarly, clonal progenitors
isolated from the mouse embryonic kidney by means of selective
growth of nephrospheres displayed broad mesodermal multi‐
potentiality (MSC‐like) but not epithelial capacity and are
thought to be derived from undifferentiated MM (Lusis
et al, 2010). We obtained similar results when single cells
derived from hFKwere seeded at low density in SCM and spindle
MSC‐like cells potentially originating from undifferentiated MMEMBO Mol Med (2013) 5, 1556–1568
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Orit Harari-Steinberg et al.or renal stroma emerged and became dominant in low passage.
In fact, long‐term self‐renewing cell clones derived from our
SCM cultures phenotypically lacked epithelial markers and
resembled propagatable MSC populations commonly isolated byFigure 4.
EMBO Mol Med (2013) 5, 1556–1568 adhesion culture (Bruno et al, 2009; Dekel et al, 2006c).
Importantly, in the chick CAM graft assay MSCs used as
controls do not epithelialize to become nephron cell types
(Buzhor et al, 2011). In contrast, when stimulated in vitro with2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 1563
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1564serum‐free deﬁned conditions unsorted single hFK cells
proliferated and readily acquired distinct morphology, inherent
epithelial markers such as EpCAM and epithelial lineage
commitment. NCAM1‐expressing hNPCs, isolated from hFK
cells expanded in SFM, are therefore clearly different both
phenotypically and functionally from MSCs or MSC‐like cells.
At present it is not possible to precisely identify the
developmental stage the hNPCs originate from. Although
the SFM culture conditions enrich the cultures as a whole for
epithelial markers, the NCAM1þ sub‐population appears to be
less differentiated, as shown by their loss of CDH1/E‐CAD and
increase in SIX2 expression. During mouse kidney development
expression of Cdh1/E‐cad and Six2 was found to be almost
mutually exclusive, with the exception of the cells that are going
through the MET. One possibility is therefore that the hNPCs are
this minor subset of E‐CAD/SIX2þ/NCAM1þ cells. It is however
not clear if these cells are truly expressing both SIX2 and E‐CAD,
or the observed co‐expression is the result of SIX2 protein
stability after its expression has been stopped. Alternatively, the
hNPCs could be the complete SIX2þ sub‐population of the
NCAM1þ cells and therefore be derived from the CM. Further
fractionation of the NCAM1þ population in mouse and human
may separate early (NCAM1þSIX2þ) and more committed
nephron progenitors (NCAM1þSIX2) and indicate functional
potency. This was recently evident in Wilms’ tumour for which
an additional marker (ALDH) within the NCAM1þ fraction was
used to more precisely pinpoint cancer stem/initiating cells in
the tumour (Pode‐Shakked et al, 2013). We therefore, at this
stage, collectively consider foetal human progenitors expressing
NCAM1 as a pool of mitotically competent yet strongly nephron‐
generating‐biased cells.
Neither haematopoietic stem cells (HSCs) nor MSCs, the most
accessible human stem cells, can be used to derive stem/
progenitor cells capable of generation of renal components
(Almeida‐Porada et al, 2002; Harari‐Steinberg et al, 2011; Krause
& Cantley, 2005; Pleniceanu et al, 2010). The ability of hNPC
within their capacity to carry out developmental functions and
unequivocally generating human renal structures encouraged us
to investigate the possibility of injecting hNPCs to restore
function inmodels of kidney failure (Harari‐Steinberg et al, 2011;Figure 4. hNPC treatment in the 5/6 Nx chronic renal injury model.
A,B. hNPCs engraft into 5/6 Nx mouse kidneys: (A) hNPCs were labelled with CM-
with saline served as controls. Two weeks after cell injection the kidneys we
(BF), fluorescence field in red (FF) and merged images of a healthy kidney (na¨
RT-PCR for human-specific b2-microglobulin (hb2m) demonstrates a repres
but not in untreated (naı¨ve) or saline-injected kidneys. Mouse b-actin (mb
C,D. hNPCs halt disease progression and improve CrCl: (C) Injection of hNPCs into
of renal function deterioration, compared to saline-treatedmice. (D) hNPC-tr
compared to baseline levels (DT CrCl) in contrast to saline-treated mice. p
E–M. hNPCs integrate into existing tubules and regenerate new tubules: Injected
panel and M) and a human-specific epithelial marker, panCK/MNF116 (H–L)
tubule-like structures (arrowheads), as demonstrated by IF HLA staining (E). H
with DAPI (overlay, right). (H and I) Various modes of engraftment are high
(I; panCK) and tubular regeneration (J–M representing consecutive sections
(K)Mature tubules stained for HLA and panCK. (L) A human panCK expressing
marker, EMA (lower image) (M) Staining for HLA (upper image) and cross-r
regenerating proximal tubule type.
 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.Pleniceanu et al, 2010). Importantly, we could show beneﬁcial
effects of hNPC on improved renal function in a mouse model of
chronic progressive renal injury that mimics more closely CKD in
humans. Since hNPC long‐term engrafted in the 5/6 Nx chronic
injury model to produce kidney epithelium (even at 3 months
post‐hNPC injection) demonstrating regenerative potential in
the remnant kidney, we hypothesize that such increases from
baseline CrCl adhere at least in part to epithelial lineage
differentiation of hNPCs and functional restoration. Neverthe-
less, tissue stem/progenitors have potential to decrease
inﬂammation and oxidative stress and to improve angiogenesis
processes altered in CKD to create a proper renal microenviron-
ment (Yasuda et al, 2010). With the level of integration observed
delineation of the molecular mediators and functional effectors
of hNPC is required to assess the relative contribution of
differentiation‐dependent and ‐independent mechanisms in
CKD. Altogether, while our data suggest a reparative potency
for hNPC and provides cautions optimism for proceeding with
allogeneic renal stem/progenitor cell therapy (ideal for clinical
scenario in which CKD patients are already subscribed with an
immunosuppressive drug), the absence of a signiﬁcant improve-
ment in changed CrCl following the ﬁrst and second injections of
hNPC and the improvement observed at 10 weeks (after three
injections) suggest that in the chronic scenario sustained
improvement in CrCl may require repeated injections leading
to cumulative effects of hNPCs rather than single administration.
These results imply the anticipated use of large cell numbers and
highlight the importance in developing tools for more robust
clonogenic self‐renewal of hNPC and ex vivo expansion. In this
regard, BMP7 showed a positive effect on hNPC growth in
accordance with data in mice (Blank et al, 2009; Dudley
et al, 1999). Nevertheless, deciphering additional factors to
further maintain committed nephron stem/progenitors (within
the NCAM1þ fraction) is warranted. Finally, as congenital
human kidneymalformations are fundamentally disorders of the
renal progenitor pool, cultured hNPCs with their ability to
engraft and regenerate in hosts may provide new opportunities
for functional analysis and disease modelling of novel inherited
mutations leading to abnormal nephrogenesis and human renal
developmental malformations (Vivante et al, 2013).Dil Cell Tracker and injected directly into the renal parenchyma. Mice injected
re analysed by the maestroCRI in vivo imaging system. Shown are bright field
ıve, left), remnant kidney treated with hNPCs (middle) or with saline (right). (B)
entative gel electrophoresis with amplification in the hNPC-injected kidneys,
-actin) served as endogenous control.
5/6 Nxmice led to a significant decrease in the proportion of mice with>15%
eated mice show a significant positive change in CrCl values at 12 weeks when
-Value <0.01.
remnant kidneys were stained for the human HLA marker (E–G, J, K—upper
. hNPCs integrated into tubules of host mouse (arrows) and regenerated new
igher magnification of e is shown in (F and G) HLA staining (green, left) merged
lighted: integration within tubules (H; panCK), integration between tubules
). (J) Small early tubules stained for HLA and panCK but not for NCAM1.
tubule (upper image) is further delineated to express the human-specific distal
eactive proximal marker ENPEP (lower image) shows human origin of a
EMBO Mol Med (2013) 5, 1556–1568
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Ethics statement
This study was conducted according to the principles expressed in the
Declaration of Helsinki and was approved by the Institutional Review
Boards of Sheba Medical Center, Wolfson Hospital and Asaf Harofeh
Medical Center. All pregnant women involved in the study provided
written informed consent for the collection of samples from their
aborted foetuses and subsequent analysis.
Establishment of a primary culture from human kidney
hFK were collected from foetuses that were aborted electively. Foetal
gestational age ranged from 15 to 23 weeks. Collected tissues were
washed with cold HBSS (Invitrogen) and minced into 1mm cubes
using sterile surgical scalpels. The dissected tissue was then incubated
for 2 h in 37°C with Iscoves’ Mod Dulbecco’s Medium (IMDM;
Invitrogen) supplemented with 0.1% collagenase IV (Invitrogen). The
digested tissue was then gradually forced through 100, 70 and 50mm
cell strainers to achieve a single cell suspension. After the digesting
mediumwas removed, the cells were resuspended in a growthmedium
(either serum-containing or serum-free medium) and plated in ﬂasks.
Serum containing medium (SCM) was comprised of IMDM (Biological
Industries) supplemented with 10% foetal bovine serum (Invitrogen),
1% Pen–strep 100M, 1% L‐glutamine (both from Biological industries),
100ng/ml EGF, 100ng/ml bFGF and 10ng/ml SCF (all growth factors
purchased from Peprotech Asia). For passaging, cells were detached
using 0.05% trypsin/EDTA (Invitrogen). Serum‐free medium (SFM) was
comprised of N2 medium (Biological Industries) supplemented with
1% Pen–strep 100M, 1% L‐glutamine, 0.4% B27 supplement (Gibco),
4mg/ml heparin sodium (Intramed), 1% non‐essential amino acids,
1% sodium pyruvate, 0.2% CD lipid concentrate (all from
Invitrogen), 2.4mg/ml glucose, 0.4mg/ml transferrin, 10mg/ml
insulin, 38.66mg/ml putrescine, 0.04% sodium selentine, 12.6mg/ml
progesterone (all from Sigma–Aldrich), 10 ng/ml FGF and 20ng/ml EGF.
For passaging, cells were detached using non‐enzymatic cell
dissociation solution (Sigma–Aldrich). The cells were observed using
Nikon Eclipse TS100 and Nikon Digital Sight cameras.
Immunoﬂorescence (IF) staining of mouse embryonic kidney
organ cultures
Kidneys from E11.5 CD1 embryos were dissected and cultured on
transwell membrane plates (Corning) for 4 days in Eagle’s MEM (Sigma)
with 10% FCS and pen/strep. Cultured kidneys were ﬁxed in 4% PFA
and antibody stained. Primary antibodies for Six2 (LifeSpan Bio-
sciences), Cdh1 (BD transduction Laboratories) and Ncam1 (Sigma) and
secondary antibodies used are summarized in Supporting Information
Table S5. Images were obtained using Nikon A1R confocal microscope
with and processed in ImageJ/Fiji software.
IF staining of cells
Cells were ﬁxed with 2% PFA with 3% sucrose in PBS (for SIX2 primary
antibody) or with 4% PFA (for vimentin and E‐cadherin) for 10min, and
washed with PBS. Cells were blocked with 5% human serum, 5%
donkey serum and 1% BSA in PBS–Tween (0.05%) followed by
incubation a primary antibodies for SIX2 (Novus), vimentin (Abcam) or
E‐cadherin (Cell Signaling) (see Supporting Information Table S5) for
1 h in room temperature. Cells were washed and then incubated with aEMBO Mol Med (2013) 5, 1556–1568 secondary antibody for 1 h in room temperature. Mounting containing
DAPI (Dapi Fluoromount‐G; SouthernBiotech, 0100‐20) was applied.
Images were obtained by Olympus BX51 ﬂuorescence microscope
using Olympus DP72 camera and cellSens standard software.
For comparative analysis between the ﬂuorescence signal of NCAM1
sorted cells, images were acquired using identical settings (exposure
and gain setting) using Zeiss AxioVision Software Package and analysed
using ImageJ software. Signal quantiﬁcation was calculated for each
nucleus by determining the nuclei area and quantization of the signal
in that area. The corrected total cell ﬂuorescence (CTCF) was calculated
as: integrated density (area of selected cellmean ﬂuorescence of
background reading).
Flow cytometry (FACS)
1105 Cells were suspended in FACS buffer (0.5% BSA, 2mM EDTA
in 1 PBS) and blocked with FcR blocking reagent (MiltenyiBiotec) and
human serum (1:1). The cells were then incubated with a primary
antibody or an isotype control (summarized in Supporting Information
Table S3). Cells were incubated with a secondary antibody if needed
(summarized in Supporting Information Table S4). Cell viability was
tested using 7AAD viability staining solution (eBioscience). Cell labelling
was detected using FACSCalibur (BD Pharmingen). FACS results were
analysed using FlowJo analysis software.
Magnetic cell sorting
Cultured hFK cells were collected, transferred through a 30mm pre‐
separation ﬁlter (Miltenyi Biotec GmbH) and then washed and
resuspended in pH 7.2 FACS buffer. Cells were magnetically labelled
with CD56 (NCAM1) magneticbeads (Miltenyi Biotec GmbH) according
to the manufacturer’s instructions. Positive labelled cells were enriched
on LS columns (Miltenyi Biotec GmbH) according to the manufacturer’s
instructions. Cell enrichment was validated using FACS.
Comparative real‐time RT‐PCR analysis of gene expression
Total RNA was isolated using RNeasy micro or mini kits (Qiagen GmbH)
according to the manufacturer’s instructions. cDNA was synthesized
using the high capacity cDNA reverse transcription kit (ABI). Real‐time
RT‐PCR (qRT‐PCR) was performed using the ABI7900HT sequence
detection system (Perkin‐Elmer/Applied Biosystems) in the presence of
TaqMan Gene Expression Master Mix or Universal PCR Master Mix
(both from ABI). qRT‐PCR ampliﬁcation was performed using TaqMan
Gene Expression Assay using StepOne plus real time RT‐PCR system
(ABI). hHPRT1 was used as endogenous control. The results were
analysed using StepOne Software v2.1 in the DDCT (such that the
expression levels of the calibrator samples¼1). Statistical analysis was
performed using a non‐paired 2‐tailed t‐test. Statistical signiﬁcance
was considered to be p‐value <0.05.
Renal differentiation of cells on chick chorio allantoic
membrane (CAM)
Fertile chicken eggs were obtained from a commercial supplier and
incubated at 37°C at 60–70% humidity in a forced‐draft incubator.
hFK cells cultured in SFM (P2) were sorted to NCAM1þ and NCAM1
subpopulations using magnetic beads, as described above. Cells were
grafted on the CAM, as described previously (Buzhor et al, 2011;
Noiman et al, 2011). On Day 9 or 10 of incubation, 1105 or
5105 cells/egg suspended in 50ml Matrigel (BD Biosciences) were2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 1565
The paper explained
PROBLEM:
The kidney is an essential organ in mammals, which removes
waste products and blood and regulates intravascular volume,
electrolyte and acid/base homeostasis. Kidney disease is
increasing at high rates. At present, dialysis and transplantation
remain the only treatment options. Nevertheless, the shortage of
available organs for transplantation continues to severely limit
the latter option. Thus, there exists a tremendous clinical need to
generate/construct/repair nephrons, the functional filtration
unit of the kidney, and improve renal function. Regenerative
medicine relies on cell transplantation, materials science, and
biomedical engineering to develop biologic substitutes that can
restore and maintain normal function of damaged or lost tissues
and organs. We and others have been investigating the
possibility of injecting functional cells to induce renal regener-
ation in models of kidney failure. The first challenge is to identify
a stem cell capable of generation of renal components. Neither
haematopoietic stem cells (HSCs) nor mesenchymal stem cells
(MSCs), the most accessible human stem cells, can be used to
derive true renal progenitors. Given this lack of an easy source for
renal stem cells, we looked for an alternative source.
RESULTS:
Formation of kidney tissue during embryonic development
requires the generation of kidney precursor cells and their
subsequent differentiation into functional nephron units.
Therefore, a source for renal progenitor cells is the developing
kidney. We therefore went on to identify stem/progenitor cells
from within this tissue. Using defined serum free culture
conditions that were adopted from studies on epithelial stem
cells and specifically stimulate growth of the renal epithelial
lineage and immunosorting according to NCAM1, we
succeeded for the first time in prospectively isolating mitotically
active human epithelial nephron progenitors (hNPCs). We
show that hNPCs have primitive characteristics expressing
distinct nephron progenitor markers and are highly clonogenic.
Moreover, when grafted in aggregates onto the chorioallantoic
membrane (CAM) of the chick embryo these cells proved robustly
to generate renal structures. Collectively, foetal NCAMþ cells
exhibited broad nephron epithelial differentiation (proximal,
loop of Henle and distal tubules (data not shown), while in
contrast grafting of control MSCs leads to generation of a
disorganized cell mass. Finally we show the beneficial effects of
hNPCs in a mouse model of chronic renal injury that mimics
a common clinical condition in humans harboring chronic kidney
disease (CKD).
IMPACT:
The identification of hNPCs represents advancement in stem cell
science and renal medicine and paves the way to developing
novel renal regenerative therapies in humans.
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1566pipetted into an approximately 0.8 cm plastic ring placed on the
CAM (ﬁve replicates). The eggs were then incubated for an additional
5–7 days. Cell grafts were photographed after removal using a Scion
Corporation colour digital camera (model CFW‐1612C) attached to an
Olympus SZX12 (model SZX‐ILLB200). Grafts were ﬁxed overnight in
4% buffered paraformaldehyde and embedded in parafﬁn. Three grafts
were sampled from each treatment group for haematoxylin and eosin
(H&E) staining, and one was also used for immunohistochemical (IHC)
and immuoﬂuorescence (IF) staining.
H&E staining of parafﬁn‐embedded CAM grafts
Six micrometre sections of parafﬁn‐embedded CAM grafts were
mounted on super frost/plus glass and incubated at 60°C for 40min.
After deparafﬁnization, slides were incubated in Mayer’s haematoxylin
solution (Sigma–Aldrich) and incubated with 1% HCl in 70% ethanol
for 1min. Slides were then incubated for 10 s in eosin (Sigma–Aldrich).
Images were produced using Olympus BX51TF and Scion colour and
monochrome digital cameras.
IHC and IF staining of parafﬁn‐embedded CAM grafts
Graft sections were mounted on super frost/plus glass, as described
above, and deparafﬁnized. After 15min of incubation in 3% H2O2 in
methanol, antigen retrieval (only in THG staining) was performed by
boiling the slides for 15min in a 0.01M sodium citrate buffer (using a 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.microwave oven). Slides were then blocked with 1% BSA in PBS for
15min and incubated overnight at 4°C with a primary antibody (see
Supporting Information Table S5). In the negative control samples, the
primary antibody was substitute with non‐immune serum. When IHC
staining was carried out, a biotinylated second antibody was applied
for 1 h, followed by incubation with horseradish peroxidase‐conjugat-
ed streptavidin (HRP‐SA) for 10min. The immunoreaction was
visualized by an HRP‐based chromogen/substrate system, including
DAB (brown) chromogen (liquid DAB substrate kit—Zymed) according
to the manufacturer’s instructions. The sections were then counter-
stained with Mayer’s haematoxylin solution, dehydrated and mounted
for microscopic examination. Images were obtained using a Scion
Corporation grayscale digital camera (model CFW‐1312M) attached to
an Olympus BX51 (model BX51TF). When IF staining was performed
slides were incubated for 1 h with a secondary antibody (see
Supporting Information Table S5) at room temperature and counter-
stained with 0.1mg/ml Hoechst in PBS for 5min. Slides were then
coverslipped in an anti‐fade medium [90% glycerol (Sigma–Aldrich)
with 10% PBS and 1% nPropyl gallate (Sigma–Aldrich)]. Images were
obtained using an Olympus AX70 motorized microscope, and spectral
unmixing using amultispectral imaging system (NuanceFX camera and
software) was applied, as described previously (Noiman et al, 2011)
due to the strong autoﬂuorescence present in both the grafted tissue
and the hFK sections.EMBO Mol Med (2013) 5, 1556–1568
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mice
Mice at 9–12 weeks of age were subjected to two‐step 5/6
nephrectomy under halothane anaesthesia (Kasiske et al, 1988;
Kennedy et al, 2003). This model was used to evaluate the therapeutic
properties of hNPCs. One week after the second session, 5105 cells
were injected directly into the parenchyma of the remnant kidney in
three separate injections at intervals of 3 weeks between injections.
Two weeks after each cell injection, 24 h urine samples were collected
using metabolic cages and blood samples were collected from the
retro‐orbital sinus. On the 10th week mice were fed by high protein
food followed by a fourth blood and urine sample collection. Fourteen
weeks after the second Nx session, the mice were sacriﬁced and the
kidneys were removed for IHC analysis. CrCl in ml/min was calculated
using the following formula:
CrCl ¼ UCr  24h volume
PCr  24 60min
IHC and IF staining of parafﬁn‐embedded human and mouse
kidney tissues
Sections were pre‐treated using OmniPrep solution (Zytomed Systems)
in 95°C for 1 h according to manufacturer’s protocol. Blocking was
performed using Cas‐Block solution (Invitrogen) for 20min followed by
1 h of incubation with a primary antibodies (Cytokeratin, HLA, EMA,
EnPEP or NCAM1; see Supporting Information Table S5). Samples were
incubated in secondary antibody (see Supporting Information Table S5)
for 30min in room temperature and detected using DAB kit (Cell
Marque) or Red Substrate Kit (Vector), both according to manufac-
turers’ protocols. Haematoxylin was used for counterstaining. For IF
staining, sections were blocked with 5% human serum, 5% donkey
serum and 1% BSA in PBS‐Tween (0.05%) for 1 h followed by
incubation with the primary antibody for HLA (Supporting Information
Table S5) and then washed and incubated with secondary antibody
(Supporting Information Table S5) for 1 h. Mounting containing DAPI
was applied.
For more detailed Materials and Methods see the Supporting
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